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age and had no impact on bone morphology. Adaptation to low and high phosphate diet were similar in
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Renal Dnase1 expression 
is regulated by FGF23 but loss 
of Dnase1 does not alter renal 
phosphate handling
Daniela Egli‑Spichtig1, Martin Y. H. Zhang1, Alfred Li2, Eva Maria Pastor Arroyo3, 
Nati Hernando3, Carsten A. Wagner3, Wenhan Chang2 & Farzana Perwad1,4* 
Fibroblast growth factor 23 (FGF23) is a bone‑derived endocrine hormone that regulates phosphate 
and vitamin D metabolism. In models of FGF23 excess, renal deoxyribonuclease 1 (Dnase1) mRNA 
expression is downregulated. Dnase‑1 is an endonuclease which binds monomeric actin. We 
investigated whether FGF23 suppresses renal Dnase‑1 expression to facilitate endocytic retrieval of 
renal sodium dependent phosphate co‑transporters (NaPi‑IIa/c) from the brush border membrane by 
promoting actin polymerization. We showed that wild type mice on low phosphate diet and Fgf23−/− 
mice with hyperphosphatemia have increased renal Dnase1 mRNA expression while in Hyp mice with 
FGF23 excess and hypophosphatemia, Dnase1 mRNA expression is decreased. Administration of 
FGF23 in wild type and Fgf23−/− mice lowered Dnase1 expression. Taken together, our data shows that 
Dnase1 is regulated by FGF23. In 6‑week‑old Dnase1−/− mice, plasma phosphate and renal NaPi‑IIa 
protein were significantly lower compared to wild‑type mice. However, these changes were transient, 
normalized by 12 weeks of age and had no impact on bone morphology. Adaptation to low and high 
phosphate diet were similar in Dnase1−/− and Dnase1+/+ mice, and loss of Dnase1 gene expression did 
not rescue hyperphosphatemia in Fgf23−/− mice. We conclude that Dnase‑1 does not mediate FGF23‑
induced inhibition of renal tubular phosphate reabsorption.
Fibroblast growth factor 23 (FGF23) is a bone-derived endocrine factor that regulates phosphate homeosta-
sis and vitamin D  metabolism1. In the kidney, FGF23 binds to FGF receptors 1, 3 and 4 in the presence of its 
obligate co-receptor, αKlotho, to inhibit renal phosphate reabsorption and suppresses 1,25 dihydroxyvitamin 
D (1,25(OH)2D) levels by inhibiting its synthesis and accelerating its  degradation
2–4. FGFR-Klotho receptor 
activation by FGF23 leads to phosphorylation of extracellular signaling regulated kinase (ERK 1/2). P-ERK1/2 
induces the internalization of sodium phosphate co-transporter IIa (NaPi-IIa) and IIc (NaPi-IIc) from the renal 
brush border membrane and decreases 1,25(OH)2D production by downregulation of Cyp27b1 and upregula-
tion of Cyp24a1 gene expression,  respectively2,5. Further, FGF23 increases renal expression of the transcription 
factor, early growth response 1 (Egr1) via P-ERK 1/2-dependent  pathway5. Egr1 knockout (Egr1−/−) mice have 
similar plasma phosphate and 1,25(OH)2D levels as wild-type (WT) mice but the phosphaturic response to 
exogenous FGF23 is impaired while FGF23 mediated suppression of 1,25(OH)2D production is  intact
6. Hence, 
FGF23 regulates phosphate but not 1,25(OH)2D levels in an Egr-1-dependent  manner
6.
Deoxyribonuclease 1 (Dnase1) was among the top downregulated genes in the kidney in several studies that 
investigated the mechanisms by which FGF23 regulates renal phosphate and vitamin D metabolism. Specifically, 
comparative transcriptome analysis of Egr-1 chromatin immunoprecipitation sequencing (CHIP-seq) data of 
WT mice treated with FGF23 and microarray data of FGF23-treated WT mice, and Col4a3 knockout and Fgf23 
transgenic mice revealed that FGF23 down regulates renal Dnase1 mRNA  transcription6,7. FGF23 recruits Egr-1 
to an active regulatory region 7.7 kb upstream of the transcription start site of the Dnase1 gene. Intraperito-
neal (i.p.) FGF23 injections suppress Dnase1 mRNA expression in WT mice but this effect is partially blocked 
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in Egr1−/−  mice6. Conversely, when plasma FGF23 and phosphate levels are lowered in Hyp and WT mice by 
dietary phosphate restriction, renal Dnase1 expression is increased by several  fold8 suggesting that Dnase1 may 
be involved in FGF23-Egr-1-dependent-regulation of phosphate homeostasis.
Dnase-1 is an endonuclease which digests double stranded  DNA9. The less recognized function of Dnase-1 is 
its interaction with monomeric actin (g-actin)9; Dnase-1 prevents actin polymerization and promotes depolym-
erization of filamentous actin (f-actin)10,11. Recently, Dnase1 was shown to be expressed in many tissues includ-
ing kidney, duodenum and  liver12 and previous studies have shown that actin polymerization and cytoskeleton 
assembly is important for sodium dependent phosphate cotransporter  regulation13. Whether FGF23 suppresses 
renal Dnase1 gene expression and thereby promotes actin polymerization to facilitate endocytic retrieval of 
NaPi-IIa from the brush border membrane is not known. In this study, we characterized the Dnase1−/− mouse 
model with respect to renal phosphate handling and determined whether loss of Dnase1 gene expression rescues 
the hyperphosphatemic phenotype in Fgf23−/− mice.
Results
Dietary phosphate and FGF23 regulate renal Dnase1 gene expression. Dnase1 mRNA expres-
sion was analyzed in WT mice fed either low (0.02%), normal (0.6%) or high (1.65%) phosphate diet for 4 days, 
and in mouse models of FGF23 excess and deficiency (Fig. 1a–d). In WT mice fed a low phosphate diet, Dnase1 
mRNA expression increases 1.7-fold when compared to a normal phosphate diet. In WT mice fed a high phos-
phate diet, Dnase1 mRNA expression was suppressed twofold when compared to a low phosphate diet but was 
not significantly different from normal phosphate diet (Fig. 1a). The Hyp mouse is a model of FGF23 excess 
wherein an inactivating mutation of the Phex gene stimulates FGF23 production in bone thereby increasing 
plasma FGF23 levels inducing renal phosphate wasting and  hypophosphatemia14,15. In Hyp mice, we observed 
that renal Dnase1 mRNA expression was downregulated fourfold compared to WT mice (Fig. 1b). In WT mice, a 
single injection of recombinant FGF23 decreased renal Dnase1 mRNA expression after 5 h (Fig. 1c). In contrast, 
loss of Fgf23 gene expression in Fgf23−/− mice upregulated renal Dnase1 mRNA but this effect was reversed by 
infusion of recombinant FGF23 (Fig. 1d). These findings together with previously published genomic data in 
 mice6–8 demonstrate the regulation of Dnase1 mRNA expression by dietary phosphate and FGF23.
Increased iFGF23 levels and renal phosphate leak in young Dnase1−/− mice does not impact 
bone health. To investigate the role of Dnase-1 in phosphate and FGF23 metabolism, we characterized the 
global Dnase1−/− mouse model at 6 and 12 weeks of age. Dnase1−/− mice were born with a normal Mendelian 
Figure 1.  Dnase1 mRNA expression dependent on phosphate diet and FGF23 levels. Relative renal Dnase1 
mRNA expression in (a) 12 week old WT mice fed for 4 days either low (black triangle), normal (gray square) 
or high (gray circle) phosphate diet, (b) in 9 weeks old WT (gray square) and Hyp (black triangle) mice, (c) in 
WT mice injected with a single dose of vehicle (gray square) or recombinant FGF23 (150 ng/g) (black triangle) 
1 and 5 h after injection, and (d) in 6 week old Fgf23+/+ and Fgf23−/− mice infused with vehicle (gray square) or 
recombinant FGF23 (200 ng/g) (black triangle) for 4 days. 18SrRNA (a) or Gus (b–d) were used as housekeeping 
genes and values were normalized to vehicle group. 3–7 mice per group. ANOVA (a,d) with Tukey’s multiple 
comparisons test or Student’s t-test (b,c), *p < 0.05.
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distribution and grew similar to their control littermates evident from normal body weight and two-kidney 
per bodyweight ratio (Supplementary Fig.  S1). Plasma iFGF23 increased significantly by 45% in 6  week old 
Dnase1−/− mice compared to Dnase1+/+ mice whereas there was no change in plasma cFGF23, PTH, 1,25(OH)2D 
and creatinine levels (Fig. 2a–d and Supplementary Fig. S2). Higher FGF23 levels in 6 week old Dnase1−/− mice 
resulted in lower plasma phosphate but urinary fractional excretion of phosphate was unchanged. Serum cal-
cium levels were also higher in 6  week old Dnase1−/− mice but urinary fractional excretion of calcium was 
unchanged (Fig. 2e–h). Fgf23, Galnt3 and Fam20c mRNA expression in bone were similar in Dnase1−/− com-
pared to Dnase1+/+ mice (Supplementary Fig. S2). In 12 week old Dnase1−/− mice, there was no difference in 
plasma and urine parameters compared to Dnase1+/+ mice (Fig.  2). BUN levels were similar in 12  week old 
Dnase1−/− mice compared to Dnase1+/+ mice suggesting normal renal function (Supplementary Fig.  S3). In 
6 week old Dnase1−/− mice, the changes in FGF23 and phosphate levels were accompanied by decreased abun-
dance of sodium dependent phosphate co-transporter NaPi-IIa, but not NaPi-IIc at the renal BBM compared 
to Dnase1+/+ mice (Fig. 3a,b). Localization of NaPi-IIa at the apical membrane was confirmed by immunofluo-
rescence and was unchanged in Dnase1−/− compared to Dnase1+/+ mice (Supplementary Fig. S4). In 12 week 
old Dnase1−/− mice there was no change in abundance of NaPi-IIa and NaPi-IIc at the renal BBM compared to 
Dnase1+/+ mice (Fig. 3c,d). Renal Klotho protein expression was reduced in 6 week old Dnase1−/− mice com-
pared to Dnase1+/+ mice but ERK1/2 phosphorylation, a downstream FGF23 signaling molecule, was unchanged 
(Fig. 4). Furthermore, there were no changes in renal mRNA expression of Slc34a1, Slc34a3, Cyp27b1, Cyp24a1, 
Klotho and Egr1 in 6 week old Dnase1−/− compared to Dnase1+/+ mice (Supplementary Fig. S5). We next deter-
mined the effect of lower phosphate levels and loss of Dnase1 expression on bone morphometry in 6 week old 
Dnase1−/− mice. We observed that bone length, trabecular and cortical bone morphometry were not significantly 
different in 6 week old Dnase1−/− compared to Dnase1+/+ mice (Table 1).   
Dnase1−/− mice adapt appropriately to manipulation of dietary phosphate intake. We deter-
mined whether loss of Dnase1 gene expression has any effect on adaptation to low (0.02%) and high (1.65%) 
phosphate diet in 12 week old mice. We analyzed plasma iFGF23, PTH, 1,25(OH)2D, creatinine, phosphate, 
calcium as well as urinary excretion of phosphate and calcium but found no differences in adaptation to low 
or high phosphate diet in Dnase1−/− compared to Dnase1+/+ mice (Fig. 5). Further there were no differences in 
abundance of the sodium phosphate co-transporters NaPi-IIa and NaPi-IIc at the renal BBM between Dnase1−/− 
and Dnase1+/+ mice fed the same diet although Slc34a1 mRNA expression was significantly increased by 25% in 
Dnase1−/− compared to Dnase1+/+ mice fed a low phosphate diet (Fig. 6 and Supplementary Fig. S6). No changes 
were observed in renal mRNA expression of Slc34a3, Cyp27b1, Cyp24a1 and Egr1 in Dnase1−/− compared to 
Dnase1+/+ mice fed the same diet (Supplementary Fig. S6). Dnase1−/− mice fed a low phosphate diet had a sig-
nificant increase in renal Klotho mRNA expression by 34% compared to Dnase1+/+ mice but Klotho protein 
abundance in the kidney between Dnase1−/− and Dnase1+/+ mice was unchanged (Supplementary Figs. S6 and 
S7). Further f- to g-actin ratio was similar between Dnase1−/− and Dnase1+/+ mice fed the same diet (Fig. 7).
Loss of Dnase1 does not correct high plasma phosphate levels in Fgf23−/− mice. We evaluated 
the effect of loss of Dnase1 expression in Fgf23−/− mice on phosphate homeostasis in 6 weeks old FGF23−/−/
Dnase1−/− double knockout mice. Fgf23−/− mice develop hyperphosphatemia as early as 10 days after birth due 
to increased renal tubular reabsorption of phosphate by NaPi-IIa16. Loss of Dnase1 in Fgf23−/− mice had no effect 
on body weight, two kidneys per body weight ratio, plasma phosphate, calcium, PTH and creatinine, nor on 
urinary fractional excretion of phosphate or calcium (Fig. 8).
Discussion
FGF23 is a key player in phosphate homeostasis and vitamin D metabolism but little is known about intracel-
lular mechanisms of regulation of renal tubular phosphate reabsorption by FGF23. In this study, we confirmed 
that FGF23 and high phosphate diet downregulate the renal expression of the actin binding protein, Dnase-1, 
but loss of Dnase1 does not alter regulation of phosphate homeostasis by FGF23 in mice nor does it prevent the 
hyperphosphatemic phenotype of Fgf23−/− mice.
Dnase-1 is a monomeric-actin binding endonuclease, which prevents polymerization of g-actin and promotes 
depolarization of f-actin9–11. We confirmed that renal Dnase1 mRNA expression in WT mice is up- and down- 
regulated with low or high phosphate diet, respectively. We further demonstrate that despite the hypophos-
phatemia, Dnase1 mRNA expression in Hyp mice is downregulated as previously  described8 and despite the 
prevalent hyperphosphatemia, Dnase1 mRNA expression is upregulated in Fgf23−/− mice and is normalized by 
FGF23 infusion. Our findings suggest that plasma FGF23 concentration per se regulates renal Dnase1 mRNA 
expression and the effect of dietary phosphate is mediated via changes in circulating FGF23. These observations 
confirm the results of a comparative transcriptome analysis where Dnase1 was one of the most downregulated 
genes in three mouse models of FGF23 excess, the Col4a3 knockout mouse, FGF23 transgenic mouse and the 
Hyp  mouse7. Together, these data clearly demonstrate that Dnase1 mRNA expression is regulated by FGF23.
We have previously shown by ChIP-seq analysis that downregulation of Dnase1 mRNA expression in the 
kidney by FGF23 is mediated by the transcription factor Egr-16. Furthermore, Egr1−/− mice have reduced ability 
to regulate plasma phosphate levels and fail to suppress renal Dnase1 mRNA expression in response to FGF23 
 treatment6. These findings suggested that Dnase-1 plays a role in FGF23-dependent regulation of phosphate 
homeostasis. To analyze the potential role of Dnase1 in the kidney to regulate tubular phosphate transport, we 
characterized the global Dnase1−/− mouse model. Of note, deletion of Dnase1 gene in our animal model did not 
interfere with tumor necrosis factor receptor-associated protein 1 (Trap1) gene, which shares 53 base pairs with 
the untranslated region of the 3′ end of Dnase1 gene as previously  reported17,18. Dnase1−/− mice were born with 
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Figure 2.  Plasma parameters of phosphate homeostasis in Dnase1−/− mice. (a) Plasma iFGF23, (b) PTH (1–84), 
(c) 1,25(OH)2D, (d) creatinine, (e) phosphate, (f) calcium and fractional urinary excretion of (g) phosphate and 
(h) calcium in 6 and 12 week old Dnase1+/+ (gray square) and Dnase1−/− (black triangle) mice. 5–10 mice per 
group. Two-way ANOVA with Sidak’s multiple comparisons test between genotypes, *p < 0.05.
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Figure 3.  Abundance of the sodium dependent phosphate cotransporter NaPi-IIa and NaPi-IIc at the renal 
BBM of Dnase1-/- mice. (a,c) NaPi-IIa and (b,d) NaPi-IIc protein abundance at the renal BBM relative to β-actin 
in 6 (a,b) and 12 (c,d) week old Dnase1+/+ (gray square) and Dnase1−/− (black triangle) mice. 6–8 mice per 
group. Student’s t-test, *p < 0.05. Full-length blots are presented in the Supplementary File 2.
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a normal Mendelian distribution and did not have an obvious phenotype during the time points studied. Inter-
estingly, we observed a transient change in phosphate homeostasis in 6 week old Dnase1−/− mice with increased 
plasma iFGF23 but not cFGF23 and decreased plasma phosphate and abundance of NaPi-IIa at the brush border 
membrane. For unknown reasons, there was no change in urinary fractional excretion of phosphate despite 
elevated plasma iFGF23 and low plasma phosphate levels. We speculate that other phosphate cotransporters may 
mediate increased phosphate reabsorption to compensate for the decreased abundance of NaPi-IIa in response 
to hypophosphatemia. For example, it has been shown that rats at weaning age have higher levels of NaPi-IIc 
protein compared to adult  rats19. NaPi-IIc significantly contributes to phosphate transport in the weaning but 
not adult rats as shown by injection of renal poly(A) + RNA of weaning and adult rats to oocytes and depleting 
Figure 4.  Klotho protein expression and ERK1/2 phosphorylation in kidneys of Dnase1−/− mice. (a) Renal 
Klotho protein expression relative to β-actin and (b) ERK1/2 phosphorylation relative to total ERK1/2 in 6 week 
old Dnase1+/+ (gray square) and Dnase1−/− (black triangle) mice. 6–7 mice per group. Student’s t-test, *p < 0.05. 
Full-length blots are presented in the Supplementary File 2.
Table 1.  Bone morphometry Dnase1 KO mice. MicroCT Analysis of bone length, trabecular bone at distal 
femur and cortical bone at the tibia-fibular junction in 6-week-old Dnase1+/+ and Dnase1−/− mice. N = 3–5 
animals, SD = standard deviation, Student’s t-test.
Measurement
Dnase1+/+ Dnase1−/− t-test
Mean ± SD Mean ± SD p-value
Bone length
Femur length (mm) 12.747 ± 0.214 12.560 ± 0.235 0.3052
Tibia length (mm) 15.110 ± 0.106 15.010 ± 0.143 0.3393
Trabecular bone morphometry distal femur
BV/TV 0.110 ± 0.002 0.109 ± 0.017 0.9442
Connectivity Density 277.424 ± 37.504 278.511 ± 27.574 0.9635
Trabecular number 5.379 ± 0.265 5.379 ± 0.200 0.9969
Trabecular thickness 0.034 ± 0.001 0.033 ± 0.002 0.5704
Trabecular separation 0.186 ± 0.010 0.185 ± 0.008 0.9042
Bone mineral density 151.502 ± 4.610 152.262 ± 20.016 0.9520
Cortical bone morphometry at tibia-fibular junction
BV/TV 0.572 ± 0.010 0.571 ± 0.016 0.9452
Bone mineral density 758.563 ± 42.805 768.732 ± 20.061 0.6552
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Figure 5.  Plasma parameters of phosphate homeostasis in Dnase1−/− mice dependent on phosphate diet. (a) 
Plasma iFGF23, (b) PTH (1–84), (c) 1,25(OH)2D, (d) creatinine, (e) phosphate, (f) calcium and fractional 
urinary excretion of (g) phosphate and (h) calcium in 12 week old Dnase1+/+ (gray square) and Dnase1−/− (black 
triangle) mice fed for 4 days with low, normal or high phosphate diet. 4–10 mice per group. Two-way ANOVA 
with Sidak’s multiple comparisons test between genotypes, *p < 0.05.
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NaPi-IIa or NaPi-IIc by antisense  strands19. We did not see a change in NaPi-IIc mRNA or protein at the ages 
studied but it is possible there may be changes in other phosphate cotransporter activities that compensate for 
the reduction in NaPi-IIa. Alternatively, hypophosphatemia maybe due to reduced phosphate absorption in the 
intestine or increased phosphate uptake in bone, however, we did not observe any changes in bone morphom-
etry. At 12 weeks of age, phosphate homeostasis normalized when compared to WT littermates. We challenged 
Dnase1−/− mice with low and high phosphate diets and observed the expected changes in phosphate homeostasis 
depending on the diet but adaptation was similar in Dnase1+/+ and Dnase1−/− mice. Dnase1 binds to g-actin to 
protect cells against untimely chromatin  degradation20 and to modulate cytoskeleton plasticity. Cytoskeleton 
rearrangement is important for the regulation of sodium dependent phosphate co-transport13. In our study we 
found that loss of Dnase1 does not impact the ratio between f- and g-actin in the kidneys of Dnase1−/− mice and 
therefore we conclude that Dnase-1 does not affect actin polymerization or cytoskeleton rearrangement in the 
context of renal tubular phosphate reabsorption.
Fgf23−/− mice are hyperphosphatemic with increased renal Dnase1 mRNA expression. Loss of Dnase1 in 
Fgf23−/− mice did not rescue the high phosphate phenotype which suggests that the FGF23-dependent regula-
tion of Dnase-1 is either not involved in intracellular regulation of tubular phosphate transport or an unknown 
compensatory mechanism overcomes the Dnase1 deficiency in our mouse model. Fgf23−/− mice demonstrate 
elevated calcitriol levels at an early age  and16 calcitriol increases active transcellular phosphate uptake via NaPi-
IIb in the  intestine21. Therefore, calcitriol excess might be a dominant driver of hyperphosphatemia more than 
loss of FGF23 itself in Fgf23−/− mice. Additionally, it may also be that the actin binding property of Dnase1 has 
nothing to do with regulation of phosphate homeostasis by FGF23 and the regulation of Dnase1 by FGF23 may be 
important for other actions of FGF23 in the kidney. Dnase1 is an endonuclease and its enzyme activity is impor-
tant to remove neutrophil extracellular traps upon neutrophil activation in conditions of sterile and non-sterile 
 inflammation22. Breaking up double stranded DNA by Dnase-1 prevents the formation of anti-nuclear antibodies 
as seen in Lupus  nephritis23. It has been shown that Dnase1 treatment protected mice from acute lung injury 
(ALI) whereas Dnase1 KO mice had worse  ALI18. Interestingly, FGF23 has been shown to inhibit neutrophil 
Figure 6.  Abundance of sodium dependent phosphate co-transporter at the renal BBM of Dnase1−/− mice 
dependent on phosphate diet. (a) NaPi-IIa and (b) NaPi-IIc protein abundance at the renal BBM relative to 
β-actin in 12 week old Dnase1+/+ (gray square) and Dnase1−/− (black triangle) mice fed for 4 days with low, 
normal or high phosphate diet. 4 mice per group. Two-way ANOVA with Sidak’s multiple comparisons test 
between genotypes, *p < 0.05. Full-length blots are presented in the Supplementary File 2.
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activation, adhesion and transendothelial migration in  CKD24. However, regulation of Dnase1 by FGF23 in the 
context of inflammation and reduced neutrophil activation is unknown and needs further investigation.
In conclusion, our study provides evidence for the regulation of renal Dnase-1 expression by FGF23 and 
transient changes in phosphate homeostasis in young Dnase1−/− mice. We further demonstrate that adaptation to 
dietary phosphate supplementation and restriction is unaltered in Dnase1−/− mice and loss of Dnase1 expression 
does not rescue the high phosphate phenotype of Fgf23−/− mice.
Materials and methods
Animals. All animal studies were approved by the Institutional animal care and use committee (IACUC), 
University of California San Francisco (UCSF) (approval number AN117059-02) and were in accordance 
with the highest ethical and animal welfare standards guidelines of IACUC, UCSF. All experiments were con-
ducted in compliance with the ARRIVE guidelines. C57BL/6NDnase1tm1(KOMP)Vlcg/Tcp heterozygous mice 
(Dnase1+/−) were purchased from The Center of Phenogenomics (TCP) (Canada) and crossed with C57BL/6J 
mice (Dnase1+/+) purchased from Jackson Laboratory (USA). Heterozygous offsprings were used to generate 
homozygous Dnase1−/− mice. Mice were housed in a controlled environment with a 12:12-h light–dark cycle 
and fed ad libitum with regular chow (PicoLab Mouse Diet 20 5058). Six or twelve-week-old male and female 
mice were used for all experiments. 24-h urine was collected in metabolic cages (Tecniplast, Italy) from 6 and 
12 week old mice before they were anesthetized with Ketamine/Xylazine for subsequent blood and organ col-
lection. For the diet study, 12 week old mice were fed for 4 days either with normal (0.6% phosphorus, 0.6% cal-
cium, TD.09261), low (0.02% phosphorus, 0.6% calcium, TD.09262) or high (1.65% phosphorus, 0.6% calcium, 
TD.110217) phosphate diet (Envigo Tekland diets, USA), respectively. On the last day of the diet, spot urine 
Figure 7.  F/g actin ratio in Dnase1−/− mice dependent on phosphate diet. (a) F- and g-actin protein abundance 
and (b–d) f/g actin ratio in kidneys of 12 week old Dnase1+/+ and Dnase1−/− mice fed for 4 days with low, normal 
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Figure 8.  Bodyweight and plasma parameters of phosphate homeostasis in Dnase1−/−/Fgf23−/− double KO 
mice. (a) Body weight and (b) two-kidney per body weight ratio, plasma (c) phosphate (1–84), (d) calcium, (e) 
PTH, (f) creatinine and fractional urinary excretion of (g) phosphate and (h) calcium in 6 week old Fgf23+/+, 
Dnase1+/+ (gray square), Fgf23+/+, Dnase1−/− (black triangle), Fgf23−/−, Dnase1+/+ (gray circle), Fgf23−/−, 
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samples were collected and mice were anesthetized with Ketamine/Xylazine before blood collection and tissue 
harvest.
Heterozygous Fgf23tm1Blan (Fgf23+/−)  mice25 were crossed with Dnase1+/− mice to generate Fgf23−/−, 
Dnase1−/− double knockout mice. Six week old Fgf23−/−, Dnase1−/− double knockout mice, 9 week old Hyp mice 
(B6.Cg-PhexHyp/J) and 6 week old Fgf23−/− mice implanted with Alzet osmotic infusion pumps were used for the 
experiments when appropriate. The pump infused saline or 200 ng per gram body weight per day recombinant 
FGF23 (Genzyme-Sanofi) for 4 consecutive days. Mice were housed in a controlled environment with a 12:12-h 
light–dark cycle and fed ad libitum with regular chow (PicoLab Mouse Diet 5053).
Biochemistries. Blood was collected in BD Microtainer Tubes containing Lithium Heparin (Becton, Dick-
inson and Company) for plasma separation. Plasma and urine were aliquoted, rapidly frozen and stored at 
− 80 °C. Plasma and urine phosphate, calcium and creatinine were measured with Phosphorus Liqui-UV test, 
Calcium (CPC) LiquiColor or Creatinine LiquiColor test, respectively (EKF Stanbio, USA). BUN was measured 
by Idexx BioAnalytics (West Sacramento, CA, USA). The plasma concentration of iFGF23 (Immutopics Inter-
national, USA), cFGF23 (Immutopics International, USA), PTH (1–84) (Immutopics International, USA) and 
1,25(OH)2D (Immunodiagnostic Systems Inc, UK) were measured by enzyme-linked immunosorbent assays 
according to manufacturers’ protocols.
RNA extraction, reverse transcription and qPCR. Organs were harvested and rapidly frozen in liquid 
nitrogen. Kidneys were homogenized using a BeadBug microtube homogenizer. Total RNA from kidney was 
extracted with NucleoSpin RNA lysis buffer followed by purification with NucleoSpin RNA Miniprep (Clon-
tech, USA) according to the manufacturers’ protocol including Dnase-1 digestion. Total RNA extractions were 
analyzed for purity and concentration using the NanoDrop ND-1000 spectrophotometer. RNA samples were 
diluted to a final concentration of 100 ng/μl and cDNA was prepared with reagents from Invitrogen (USA) if 
not stated otherwise. In brief, in a reaction volume of 40 μl, 300 ng of RNA was used as template and mixed with 
the following final concentrations of RT buffer (1×):  MgCl2 (5.5 mmol/l), random hexamers (2.5 μmol/l), dNTP 
mix (500 μmol/l each) (Bioline Ltd., USA), RNase inhibitor (0.4 U/μl), multiscribe reverse transcriptase (1.25 
U/μl), and RNAse-free water. Reverse transcription was performed with temperature conditions set at 25 °C for 
10 min, 48 °C for 30 min, and 95 °C for 5 min on a thermocycler (Eppendorf). Quantitative PCR (qPCR) was 
performed using the ABI PRISM 7900HT Detection System (Applied Biosystems). Primers were designed using 
Primer 3  software26,27. Primers and probes were purchased either from Elim Biopharma (USA), IDT (USA) 
or Applied Biosystems (Eukaryotic 18S rRNA Endogenous Control primer probe set) (Table 2). Probes were 
labeled with the reporter dye FAM at the 5′-end and the quencher dye TAMRA or BHQ1 at the 3′-end. qPCR 
reactions were performed using the TaqMan Fast Advanced Master Mix or PowerUp SYBR Green Master Mix 
(Applied Biosystems, USA).
Protein extraction and western blot. Protein extraction and western blot was performed as previously 
 described28,29. Organs were rapidly frozen in liquid nitrogen. Tissues were homogenized in a BeadBug microtube 
homogenizer with buffer containing either 300 mM Mannitol, 5 mM EGTA, 12 mM Tris base (Sigma-Aldrich, 
USA) and 1 × complete protease inhibitor cocktail (Roche, USA) (pH 7.1) for brush border membrane (BBM) 
extraction or 20 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 M EDTA, 0.1% 
SDS (Sigma-Aldrich, USA) and 1 × protease inhibitor cocktail (Roche, USA) for total protein extraction. Brush 
border membrane vesicles were prepared using the  Mg2+-precipitation  technique30. Protein concentration was 
determined with the Pierce BCA Protein Assay Kit or the DC Protein Assay from Biorad. Twenty µg of renal 
brush border membrane for NaPi-IIa and NaPi-IIc and 50 µg (Klotho/Dnase-1) or 35 µg (P-Erk/Erk) of total 
kidney protein, respectively, were solubilized in loading buffer containing DTT and separated on 8% or 10% 
polyacrylamide gels.
For immunoblotting, proteins were transferred electrophoretically to polyvinylidene fluoride membranes 
(Immobilon-P, Millipore, USA). Membranes were blocked with Odyssey Blocking Buffer (PBS) (Li-cor, USA) or 
5% milk powder in Tris-buffered saline with 0.1% Tween-20 for 60 min followed by primary antibody incubation 
either for 2 h at room temperature or overnight at 4 °C. Primary antibodies used: rabbit polyclonal anti-NaPi-IIa 
(1:3000)31,32, rabbit polyclonal anti-NaPi-IIc (diet study) (1:750)33, chicken polyclonal NaPi-IIc (6 and 12 week 
old Dnase1−/− and Dnase1+/+ mice) (kind gift from Dr. Moshe Levi from the University of Colorado, Denver), 
mouse monoclonal anti-β-actin antibody (Sigma, St. Louis, MO; 1:5000), mouse monoclonal anti-Erk1/2 (#4370, 
Cell Signaling Technology, USA; 1:2000), rabbit monoclonal anti-Phospho-Erk1/2 (#9107, Cell Signaling Tech-
nology, USA; 1:2000), rat monoclonal anti-Klotho (Clone KM2076, TransGenic Inc., Japan; 1:1000) and mouse 
monoclonal anti-GAPDH (Merck Millipore, USA; 1:2000). Membranes were incubated with secondary anti-
bodies for 1 h at room temperature: anti-Rabbit IgG, HRP conjugate (W4018, Promega, USA), anti-Mouse IgG, 
HRP conjugate (W4028, Promega, USA), IRDye 800CW Goat anti-Rabbit IgG (P/N 925-32211), IRDye 680RD 
(P/N 925-68072), IRDye 800CW Donkey anti-Chicken IgG (P/N 925-32218), IRDye 680RD Goat anti-Mouse 
IgG (P/N 925-68070), IRDye 800CW Goat anti-Rat (P/N 925-32219), IRDye 680RD Goat anti-Rabbit IgG (P/N 
925-68071) (all Li-cor, USA). Immobilon Western (Cat.No WBKLS0500, Millipore) was used as HRP substrate. 
DIANA III-chemiluminescence detection system (Raytest, Straubenhardt, Germany) or Li-cor Odyssey Classic 
fluorescent scanner was used for signal detection. Image contrast and brightness were adjusted equally across the 
entire image using Image Studio Lite from Li-cor (https ://www.licor .com/bio/image -studi o-lite/downl oad?gclid 
=Cj0KC QiA0M D_BRCTA RIsAD Xoopa IkX18 Z5l3D wJOvt TmSeL iCm8o 5xmlU jfL-z0ZOV T2h-2oVOl wNTEa 
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F‑ and g‑actin extraction. F- and g-actin extraction was done with the G-actin/F-actin In Vivo Assay Kit 
(# BK037, Cytoskeleton, USA) according to the manufactures’ protocol.
Microcomputed tomography (μCT). Microarchitecture of the trabecular bone of the distal femur (DF), 
and of the cortical bone at the tibiofibular joint (TFJ), was measured using a Scanco Medical mCT 50 speci-
men scanner. Samples were fixed in 10% phosphate-buffered formalin and placed in 70% ethanol. Bones were 
scanned at an X-ray energy level of 55 kVp and intensity of 109 μA. The µCT 50 is calibrated monthly using a 
calibration phantom for density measurements. Trabecular bone volume fraction and microarchitecture were 
analyzed in the secondary spongiosa at the distal femur. The trabecular region of interest started adjacent and 
proximal to the femoral growth plate and extended 1 mm towards the proximal end of the femur. Cortical bone 
was analyzed in the mid-diaphysis of the tibia. The cortical region of interest started adjacent to the TFJ and 
extended proximally for 0.4 mm. Measurements included bone volume/total tissue volume (BV/TV), trabecular 
number (Tb.N.), trabecular thickness (Tb.Th.), and trabecular spacing (Tb.Sp). All scans were analyzed using 
Scanco Medical μCT evaluation software version 6.0. The evaluation script for trabecular analysis was set at 
Gaussian sigma of 0.5 and support of 2, and a lower threshold of 300. The script for cortical analysis was set at 
sigma of 0.8, support of 1, and lower threshold of 380. Representative 3D images created using Scanco Medical 
mCT Ray v4.0 software.
Immunofluorescence staining. Immunofluorescence staining was performed as previously  described29. 
Briefly, mouse kidneys were perfused through the left heart ventricle with a fixative solution containing 3.2% 
paraformaldehyde (PFA) in phosphate-buffered saline (PBS). Mouse kidneys were removed and immersed in 
3.2% PFA for additional 3 h. Next, kidneys were washed with PBS and incubated overnight in 30% sucrose in 
PBS. Kidneys were embedded in O.C.T. media and frozen in liquid propane cooled with liquid nitrogen. Then, 
Table 2.  Probe and primer sequences used for qPCR.
Gene Sequence
Mouse Slc34a1
Fwd 5′-GTC TCA TTC GGA TTT GGT GTCA-3′
Rev 5′-GCC GAT GGC CTC TAC CCT -3′
Probe 5′-CCA GAC ACA ACA GAG GCT TCC ACT TCT ATG TC-3′
Mouse Slc34a3
Fwd 5′-TAA TCT TCG CAG TTC AGG TTGCT-3′
Rev 5′-CAG TGG AAT TGG CAG TCT CAAG-3′
Probe 5′-CCA CTT CTT CTT CAA CCT GGC TGG CAT ACT -3′
Mouse Cyp27b1
Fwd 5′-CCT CTG CCG AGA CTG GGA -3′
Rev 5′-TCC CGA AAA AGG AAG TGG GT-3′
Probe 5′-TGT TTG CCT TTG CCC AGA GGCAC-3′
Mouse Cyp24a1
Fwd 5′-TAC GCT GCT GTC ACG GAG C-3′
Rev 5′-TCT GGA TTT CCC GGA GAA GTC-3′
Probe 5′-CAG TGG AGA CGA CCG CAA ACA GCT T-3′
Mouse Klotho
Fwd 5′-CAG CTC CAG GCT CGG GTA -3′
Rev 5′-AGG TGT TGT AGA GAT GCC AGA CTT T-3′
Probe 5′-TTG CCC ACA ACC TAC TTT TGG CTC ATG-3′
Mouse Gus
Fwd 5′-CTC ATC TGG AAT TTC GCC GA
Rev 5′-GGC GAG TGA AGA TCC CCT TC-3′
Probe 5′-CGA ACC AGT CAC CGC TGA GAG TAA TCG-3′
Mouse Fgf23
Fwd 5′-GAC CAG CTA TCA CCT ACA GAT CCA -3′
Rev 5′-CGG CGT CCT CTG ATG TAA TCA-3′
Probe 5′-CCC ATC AGA CCA TCT ACA GTG CCC TGA-3′
Mouse Egr1
Fwd 5′-CCT ATG AGC ACC TGA CCA CA-3′
Rev 5′-TCG TTT GGC TGG GAT AAC TC-3′
Probe Roche Universal Probe #22
Mouse Dnase1
Fwd 5′-ACT TTG TGA AAA TCC TGA GTCGC-3′
Rev 5′-AGC GGT AGG TGT CAG GTT TG-3′
Probe 5′-TCC CAC CTG GTT GCT GTT GGG AAG C-3′
Mouse Galnt3
Fwd 5′-GAG AAA GAG CGA GGG GAA AC-3′
Rev 5′-GTG GAC CAT GCT TCA TTG TG-3′
Probe 5′-ACA CCC GAC CAC CTG AAT GTA TTG AAC-3′
Mouse Fam20c
Fwd 5′-GGG AAC ATG GAT CGG CAT CA-3′
Rev 5′-GCA CTG ATG AAG AGG AGC GA-3′
Probe 5′-AAC GGG CGC GGG TTT GGG AAA TAC T-3′
13
Vol.:(0123456789)
Scientific Reports |         (2021) 11:6175  | https://doi.org/10.1038/s41598-021-84735-3
www.nature.com/scientificreports/
5 μm cryosections were cut. Slides were rehydrated/washed in PBS before they were treated for 5 min with 0.5% 
sodium dodecyl sulfate in PBS. Unspecific sites were blocked with 1% bovine serum albumin in PBS for 1 h at 
room temperature. Primary rabbit anti-NaPi-IIa antibody (kind gift from Dr. Moshe Levi from the University of 
Colorado, Denver) was diluted 1:500 in 1% bovine serum albumin in PBS and kidney sections were incubated 
with the primary antibody overnight at 4 °C. After washing with PBS, sections were incubated with the corre-
sponding secondary antibody (1:1000) [anti-rabbit Alexa594 (Invitrogen)], phalloidin-488 (1:250, Invitrogen), 
and Hoechst (1:1000, Sigma) for 1  h at room temperature. Slides were washed twice with PBS before being 
mounted with Dako glycergel mounting medium. Sections were visualized on a Leica DM 5000B fluorescence 
microscope and images processed with Leica Las X software (https ://www.leica -micro syste ms.com/produ cts/
micro scope -softw are/p/leica -las-x-ls/).
Statistical analysis. Statistics were performed using unpaired Student’s t-test, ANOVA with Tukey’s mul-
tiple comparisons analysis or Two-Way-ANOVA with Sidak’s multiple comparison analysis between genotypes 
(GraphPad Prism version 8, GraphPad, San Diego, CA). P < 0.05 was considered significant.
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